Page 136 - PCC10

Conclusion
• Pilot study: feasible and safe
• The method proved to acceptable and no
patients declined to participate
• Side effects were few and mild
• ADRC is a promising treatment option in managing ED function following RP
IFD‐Grand Solutions 2017‐Sheikh/CVR
Limitations
• Un‐blinded
• No control group
• Heterogeneouspatientsconcerningintendednerve sparing strategy
• No objective measurements for the recovery of EF
• Stem cell mechanism of action – Information on dose escalation – information on migration
– survival of cells in host IFD‐Grand Solutions 2017‐Sheikh/CVR
Page 130 of 135
136